Our findings indicate the growth suppressive effects of doxorubicin , oxaliplatin and methotrexate treatment on stomach carcinoma cells and the implication of BCL2L12 , BAX , and BCL-2 expression profiles in the molecular signaling pathways triggered by chemotherapy .